Table 1.
Baseline Characteristics of Patients with (DM) and without (non-DM) Diabetes Mellitus
| DM (n = 20) | non-DM (n = 40) | P value | |
|---|---|---|---|
| Male, n (%) | 11 (55) | 16 (40) | 0.2 |
| Age, years | 66.42 ± 7.7 | 62.23 ± 11.06 | 0.44 |
| Body mass index (kg/m2) | 31.08 ± 5.3 | 29.6 ± 5.51 | 0.18 |
| Echocardiography | |||
| Mean aortic gradient (mmHg) | 61.87 ± 25.26 | 55.12 ± 22.29 | 0.36 |
| Maximum aortic gradient (mmHg) | 86.9 ± 24.6 | 93.01 ± 24.7 | 0.11 |
| LVEF (%) | 53.13 ± 16.39 | 57.44 ± 12.58 | 0.33 |
| AVA (cm2) | 0.73 ± 0.19 | 0.72 ± 0.23 | 0.93 |
| Treatment | |||
| Beta blockers, n (%) | 11 (55) | 20 (50) | 0.61 |
| Acetylsalicylic acid, n (%) | 13 (65) | 23 (57) | 0.77 |
| Statins, n (%) | 10 (50) | 16 (40) | 0.28 |
| ACEIs, n (%) | 6 (30) | 21 (52) | 0.01 |
Data are given as mean ± SD, median (IQR) or number (percentage)
LVEF left ventricular ejection fraction, AVA aortic valve area, ACEIs angiotensin-converting enzyme inhibitors